I agree. And one of the things we have got to do is to remind those countries that are looking for investments, the trap that the PRC can create for them as they did for Montenegro.

But look, I will tell you that no matter what your skill as a facility manager, when you have pipes that have been soldered with different materials that are not particularly good for cold weather, for instance, you can be the best manager…

I am disappointed by some backsliding in the government, but where the people are very clearly committed to looking towards Europe.

Are you seeing results?

I wanted to drill down on a bill that Senator Braun and I worked on that was signed into law.

I would look forward to following up with you on that because it is obviously a critical issue not only in my area but I think for a lot of the members of this Committee and for our constituents and veterans.

I certainly agree, and I hope we will continue to stay focused on other areas where--on individuals where sanctions can help make a difference.

I hope that that is a review that also considers the implication on Afghan women and girls.

I actually have legislation that I introduced in 2022 that would authorize the DFC to invest in those kinds of telecommunications projects, because they are so critical.

If this Administration comes out with an Executive Order that includes all the reforms we are talking about today in June, that will greatly diminish the need for legislation.

Does overclassification allow Federal agencies to hide waste, fraud, and abuse?

We passed, Senator Portman and I worked on a legislation called the FENTANYL Results Act.

I appreciate that, but just getting back, one of the important functions of SBDC is disaster assistance.

By simply telling a generic drug manufacturer what adjustments they need to make, our bipartisan bill would help improve the generic market approval process and lower drug prices overall.

I appreciate that hospitals and private manufacturers may want to use this data, but I also think it is really essential that the FDA and the United States government use this data too.

This manufacturing monopoly is one of the root causes of the drug shortage, and relying on China for active ingredients is a national security and public health risk.

Thank you very much, Mr. Chair and Ranking Member Paul, for holding this hearing.

the Federal Government's current incentive and penalty structure encourages individuals to err on the side of overclassifying information rather than declassifying information.